In the present study, we observed that finerenone normalized upregulation of Ccn2 (also called connective tissue growth factor, CTGF) in DMHFD kidneys, which itself has a well established role in the pathogenesis of kidney disease in diabetes and in kidney function decline. The gene discussed is CCN2; the disease is kidney disorder.